Related Experiment Video
Updated: Jan 28, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
In silico perturbation of drug targets in pan-cancer analysis combining multiple networks and pathways
Claudia Cava1, Isabella Castiglioni1
1Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Via F.Cervi 93, 20090 Segrate, Milan, Italy.
Abstract:
The knowledge of cancer cell response to conventional therapies is crucial in order to choose the correct therapy of patients affected by cancer. The major problem is generally attributed to the lack of specific biological processes able to predict the therapy efficacy. Here, we optimized a computational method for the analysis of gene networks able to detect and quantify the effects of a drug in a pan-cancer study. Overall, our method, using several network topological measures has identified a cancer gene network with a key role in biological processes. The gene network, able to classify with a good performance cancer vs normal samples, was modulated in silico to evaluate the effects of new or approved drugs. This computational model could offer an interesting hint to decipher molecular mechanisms contributing to resistance or inefficacy of drugs.
Insights
This study presents a computational method to analyze gene networks for predicting cancer drug efficacy. The approach identifies key gene networks crucial for classifying cancer versus normal samples and evaluating drug effects.
Area of Science:
- Computational biology
- Genomics
- Cancer research
Background:
- Predicting cancer therapy efficacy is critical for patient treatment.
- A lack of specific biological markers hinders accurate prediction of treatment success.
- Understanding cancer cell response to therapy is essential.
Purpose of the Study:
- To optimize a computational method for analyzing gene networks.
- To detect and quantify drug effects in a pan-cancer study.
- To identify key gene networks involved in cancer biology.
Main Methods:
- Utilized network topological measures for gene network analysis.
- Developed a computational model for in silico drug modulation.
- Applied the method to a pan-cancer dataset.
Main Results:
- Identified a significant cancer gene network with a key role in biological processes.
- The gene network effectively classified cancer versus normal samples.
- The model evaluated the effects of approved and novel drugs in silico.
Conclusions:
- The computational model aids in deciphering molecular mechanisms of drug resistance.
- This approach offers insights into drug inefficacy.
- The method provides a valuable tool for predicting cancer drug response.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Related Concept Videos
Bioequivalence of Drugs: Drugs with Multiple Indications
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...